Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled
The FDA Law Blog
JANUARY 18, 2024
Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. 29, 2023). HHS forwards FDA’s analysis and recommendation to DEA.
69 
Let's personalize your content